4
Changes in Ownership
Hims & Hers Health, Inc. Filed Acc 0001773751-25-000124
Chief Executive Officer sold 83,994 shares at an average $28.15 ($2,364,547)
- Chief Executive Officer acquired 33,668 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dudum Andrew Chief Executive Officer | 2025-04-16 | Option exercise 10b5-1 | +17,001 | $2.43 | $41,312 | 111,896 | D: show line 1 in the form |
| Dudum Andrew Chief Executive Officer | 2025-04-16 | Option exercise 10b5-1 | +16,667 | $2.43 | $40,501 | 128,563 | D: show line 2 in the form |
| Dudum Andrew Chief Executive Officer | 2025-04-16 | Sale 10b5-1 | −33,668 | $28.02 | $943,421 | 94,895 | D: show line 3 in the form |
| Dudum Andrew Chief Executive Officer | 2025-04-16 | Sale 10b5-1 | −2,792 | $28.31 | $79,032 | 92,103 | D: show line 4 in the form |
| Dudum Andrew Chief Executive Officer | 2025-04-16 | Sale 10b5-1 | −47,534 | $28.23 | $1,342,094 | 332,728 | I: show line 5 in the form |
| Open-market sales · 83,994 sh · avg $28.15 · $2,364,547 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Dudum Andrew Chief Executive Officer | 2025-04-16 | Option exercise · Stock Option (right to buy) 10b5-1 | −17,001 | 119,011 | D: show line 6 in the form | |||||
| Dudum Andrew Chief Executive Officer | 2025-04-16 | Option exercise · Stock Option (right to buy) 10b5-1 | −16,667 | 1,173,066 | D: show line 7 in the form |
Loading xslF345X05/wk-form4_1745005205.xml…